Impaired β-cell function and insufficient β-cell mass compensation are twin pathogenic features that underlie type 2 diabetes (T2D). Current therapeutic strategies continue to evolve to improve ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...

While building a simpler model for particle interactions, scientists made a sleek new pi. Representations of pi help scientists use values close to real life without storing a million digits. The ...

When we say brain tumors, we always think of headaches as the primary symptom. However, while headaches are the most common symptom of brain tumors, patients often experience hidden warning signs that ...

Most continuous glucose monitoring metrics were not associated with HbA1c for adults with normal glycemic levels, according to a brief report published in Diabetes Technology & Therapeutics. For the ...

Everyday Health’s team of board-certified physicians and health professionals contribute to the creation and review of content, ensuring that the information is useful, up to date, and accurate. Reyna ...

Belgium: A phase 2 international trial published in The Lancet has found that low-dose antithymocyte globulin (ATG) can slow the loss of insulin-producing beta-cell function in children and young ...

Abstract: In unknown environments lacking prior maps, achieving effective visual understanding is crucial for building highly efficient task - driven autonomous navigation systems. In this paper, we ...

Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China The final, formatted version of the article will be published soon. Aims: Based on cross-sectional and follow-up ...